COVID-19: More than 12 million people receive first dose of vaccine as UK reports another 373 deaths – Sky News

Another 373 COVID-related deaths in the UK have been reported, as the total number of people to have received the first dose of a vaccine surpassed 12 million.

The number of deaths is down from the 828 deaths confirmed on Saturday.

The latest figures mean 112,465 have now died after testing positive for coronavirus since the pandemic began.

A further 15,845 infections were also confirmed on Sunday, compared to the 18,262 cases reported yesterday.

Sunday’s number of daily infections is also less than the 19,114 cases confirmed yesterday and the 20,634 reported on Thursday.

Live COVID updates from the UK and around the world

The latest government figures reveal 12,014,288 people have now had their first dose of a vaccine, while 511,447 have had both a first and second dose.

The figures mean an extra 549,078 people are now confirmed to have had their first dose compared to yesterday, while another 1,390 people have had both jabs.

The seven-day rolling average of first doses given in the UK is now 433,8571

The latest vaccination numbers are accurate up to 6 February.

They have been revealed as the vaccines minister told Sky News he is “confident” the UK will meet its “tough target” of offering everybody over 50 a jab by May.

Nadhim Zahawi said that the UK was administering doses at a rate of nearly 1,000 per minute at one point on Saturday.

Subscribe to the Daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker

It comes as the World Health Organisation’s special envoy on COVID-19 said the UK has been “vindicated” over its “brave” decision to offers vaccine doses up to three months apart.

Dr David Nabarro told Sky News’ Sophy Ridge On Sunday the move had provided the rest of the world with a “great lesson”.

The UK went against the advice of the World Health Organisation (WHO) by choosing to offer a second jab between three and 12 weeks after the first dose.

Data from the Joint Committee on Vaccines and Immunisation has so far shown reasonably high levels of protection after the first dose.